Jerry Chang, MD
Plastic and Reconstructive Surgery · Garden City, NYNPI 1518136027
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,299 of the $13,583 with a category attached, or 68.5%. 12 manufacturers reported payments, led by AbbVie at 25.8% of the total. Reporting peaked in 2024 at $3,644 and has fallen 51.9% since, to $1,753 in 2025.
Across 128 payments — averaging $106.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Axogen$3K
- Sientra, Inc.$3K
- Innovation Technologies Inc$1K
- Davol Inc.$674
- Mentor Worldwide LLC$543
- plus $1K from 6 others
What the payments were for
- Speaking & faculty fees$540%
- Grants$2,09515%
- Travel & lodging$1,36610%
- Food & beverage$9,29968%
- Education$7696%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 28 | $3,504 |
| Axogen | 22 | $3,283 |
| Sientra, Inc. | 36 | $3,242 |
| Innovation Technologies Inc | 9 | $1,185 |
| Davol Inc. | 6 | $674 |
| Mentor Worldwide LLC | 12 | $543 |
| Motiva USA, LLC | 4 | $477 |
| TELA Bio, Inc. | 4 | $323 |
| Musculoskeletal Transplant Foundation Inc. | 4 | $144 |
| Tepha Inc | 1 | $137 |
| Galderma Laboratories, L.p. | 1 | $52 |
| Smith+Nephew | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$2,622
- AVANCE NERVE GRAFT$2,604
- AxoGuard Nerve Connector$2,202
- AxoGuard Nerve Protector$2,202
- AXOGUARD HA+ NERVE PROTECTOR$2,202
- AxoGuard Nerve Cap$2,202
- Irrisept$1,110
- REVOLVE$714
- NATRELLE SALINE-FILLED BREAST IMPLANTS$714
- ALLODERM$667
- Phasix Mesh$557
- Motiva Implant Matrix$364
- MemoryGel Breast Implants$222
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$201
- GalaFLEX$137
How this compares
$13,583 in reported general payments places this provider in the 85th percentile of 219 plastic and reconstructive surgery providers in New York.
See all plastic and reconstructive surgery providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other plastic and reconstructive surgery in Garden City
- Thomas DavenportGarden City$2.8M
- Matthew KilgoGarden City$14K
- Noel NatoliGarden City$11K
- Haritha VeeramachaneniGarden City$7K
- Finny GeorgeGarden City$6K
- Barry DouglasGarden City$5K
- Alexander DagumGarden City$5K
- Howard LangsteinRochester$350K
- James BradleyNew Hyde Park$306K
- David FuntWoodmere$295K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.